Spectre Corporation v. United States

CourtUnited States Court of Federal Claims
DecidedJuly 26, 2022
Docket16-932
StatusPublished

This text of Spectre Corporation v. United States (Spectre Corporation v. United States) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Spectre Corporation v. United States, (uscfc 2022).

Opinion

In the United States Court of Federal Claims No. 16-932 (Filed: 26 July 2022)

*************************************** SPECTRE CORPORATION, * * Plaintiff, * * Evidence; Admissibility of Layperson v. * Testimony; Admissibility of Expert * Testimony; Hearsay; Fed. R. Evid. 701; THE UNITED STATES, * Fed. R. Evid. 702; Fed. R. Evid. 802. * Defendant. * * ***************************************

James W. Wiggin III, of Columbus, OH, for plaintiff.

Andrew J. Hunter, Trial Attorney, Commercial Litigation Branch, Civil Division, of the U.S. Department of Justice, with whom were Brian M. Boynton, Acting Assistant Attorney General, and Patricia M. McCarthy, Director, all of Washington, DC, for defendant.

OPINION AND ORDER

HOLTE, Judge.

Plaintiff Spectre Corporation manufactures and sells pressure sensors to be used in various industries, including automotive, oil and gas, aviation, and aerospace. Spectre executed two contracts with NASA to license and commercialize NASA’s patented silicon carbide pressure sensor technology. Plaintiff alleges NASA breached both contracts and implied covenants of good faith and fair dealing, for which plaintiff seeks compensatory damages and lost profits. After a period of discovery, the government filed a motion for partial summary judgment and three motions in limine to exclude certain witness testimony, including: (1) a motion to exclude a packaging cost estimate prepared by Spectre’s employee Mr. Jeffrey Votypka; (2) a motion to exclude testimony about sales projections provided by Spectre’s CEO Mr. Jack Keller and salesman Mr. Nicholas Carollo; and (3) a motion to exclude materials prepared by Dr. Chris Melkonian, plaintiff’s former expert, and portions of Dr. Leland Spangler’s testimony relying on Dr. Melkonian’s materials. Plaintiff responded with a motion in limine to exclude testimony and evidence provided by the government’s expert Dr. Aaron Knobloch. The Court stayed consideration of the government’s motion for partial summary judgment pending resolution of the parties’ motions in limine. For the following reasons, the government’s motion in limine to exclude Mr. Votypka’s packaging cost estimate and the government’s motion in limine to exclude materials prepared by Dr. Melkonian and portions of Dr. Spangler’s testimony relying on Dr. Melkonian’s materials are granted. The government’s motion in limine to exclude portions of Mr. Keller’s and Mr. Carollo’s testimony is granted-in- part and denied-in-part. Plaintiff’s motion in limine to exclude portions of Dr. Knobloch’s testimony is denied.

I. Procedural and Factual Background

Plaintiff Spectre Corporation (“Spectre”) and the United States through the National Aeronautics and Space Administration (“NASA”) executed two agreements to commercialize pressure sensor technology NASA developed and patented. The first agreement, SAA3-210 (“Space Act Agreement”) executed on 22 December 2011, sets forth NASA’s and Spectre’s obligations to commercialize NASA’s silicon-carbide sensor technology. See Compl. Ex. 3 at 5– 21 (Space Act Agreement), ECF No. 1-3. The second agreement, DE-456 (“Exclusive License Agreement”) executed on 14 May 2012, granted Spectre a royalty-bearing, exclusive license to practice the silicon-carbide sensor patents through 25 January 2025, the end of the patents’ terms, and required Spectre to pay a $50,000 fee to NASA. See Compl. Ex. 1 at 1–17 (Exclusive License Agreement), ECF No. 1-1; Compl. Ex. 2 at 1–14 (Exclusive License Agreement), ECF No. 1-2; Compl. Ex. 3 at 1–3 (Exclusive License Agreement), ECF No. 1-3. Around the same time, Spectre applied for and received a $1,000,000 grant from the State of Ohio to commercialize the sensor technology. See Compl. Ex. 3 at 23–84 (Ohio Grant), ECF No. 1-3.

After delays and conflicts affecting the performance of obligations under the contracts, NASA terminated the Exclusive Licensing Agreement and halted its performance under the Space Act Agreement, allowing the Space Act Agreement to expire by its own terms. Compl. at 4, ECF No. 1. Plaintiff brought this action for breach of the Space Act Agreement and the Exclusive Licensing Agreement claiming $215,000 for fees paid to NASA, at least $2,000,000 for money spent on the failed project, and more than $45,000,000 in lost profits. See Compl.

To support its claims for lost profits, plaintiff submitted a lost profits model which purports to estimate the profits Spectre would have enjoyed if NASA had fully performed its contractual obligations. See Def.’s Mot. Exclude Keller & Carollo App. at Appx1–11 (Pl.’s Second Interrogs. Answers), ECF No. 114-1. The lost profits model comprises thirteen sheets, including a summary, projected gross sales, net lost profits, actual financial performance, projected lost profits by year, a costing matrix, and extended pricing predictions. Id. at Appx4–7 (Pl.’s Second Interrogs. Answers). None of these pages were submitted with the parties’ briefing, but the government submitted a summary of the sales projections and a net profit comparison. Id. at Appx129 (Spectre SiC Sales Projections), Appx130 (Net Profit Comparison). The lost profits calculations rely in part on three sources: (1) cost information provided by Spectre’s engineer and project manager Mr. Votypka, (2) cost information provided by plaintiff’s expert Dr. Spangler, and (3) sales projections provided by Spectre’s CEO Mr. Keller and salesman Mr. Carollo.

A. Dr. Spangler’s Fabrication Cost Estimate

Plaintiff’s initial expert discovery disclosure identified Dr. Melkonian as an expert witness and stated he would offer testimony about the estimated commercial cost to fabricate silicon carbide pressure sensors, among other things. Pl.’s Initial Disc. Disclosure at 13, ECF No. 126-3. Dr. Melkonian, however, withdrew after plaintiff filed its initial discovery disclosure

-2- due to an unanticipated conflict of interest, leaving plaintiff with an incomplete fabrication cost estimate and no expert witness to testify. Joint Status Report at 2, ECF No. 97. Plaintiff quickly located a new expert, Dr. Spangler, but—not wanting to duplicate costs—asked Dr. Spangler to review Dr. Melkonian’s work on the fabrication cost estimate and endorse it as his own if appropriate. Joint Status Report at 2; 25 Mar. 2022 Oral Arg. Tr. (“Tr.”) at 157:11–25, ECF No. 132. Dr. Spangler reviewed Dr. Melkonian’s partial cost estimate, made some changes, and endorsed it. See Def.’s Mot. Exclude Spangler App. at Appx2–4 (Spangler Report), ECF No. 113-1.

B. Mr. Votypka’s Packaging Cost Estimate

Dr. Spangler’s cost estimate was limited to the cost to fabricate the silicon carbide die, or internal components of the silicon carbide pressure sensor. These internal components must be packaged in a housing using NASA’s patented process to ensure they function reliably. Compl. at 21. Plaintiff’s project manager and engineer Mr. Votypka prepared an estimate of the labor and materials necessary to calculate the cost of carrying out the packaging process as he understood it. See Def.’s Mot. Exclude Votypka at Appx78 (Spectre SiC Costing), ECF No. 112-1. Together, Mr. Votypka’s packaging cost estimate and Dr. Spangler’s fabrication cost estimate comprise the total cost to manufacture the silicon carbide pressure sensors.

C. Mr. Keller’s and Mr. Carollo’s Sales Projections

Mr. Keller’s and Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kelly v. Syria Shell Petroleum Development B.V.
213 F.3d 841 (Fifth Circuit, 2000)
Mississippi Chemical Corp. v. Dresser-Rand Co.
287 F.3d 359 (Fifth Circuit, 2002)
United States v. Ronald Keith Brown
415 F.3d 1257 (Eleventh Circuit, 2005)
Bourjaily v. United States
483 U.S. 171 (Supreme Court, 1987)
General Electric Co. v. Joiner
522 U.S. 136 (Supreme Court, 1997)
United States v. Wilson
605 F.3d 985 (D.C. Circuit, 2010)
Harvey Ward Locke v. United States
283 F.2d 521 (Court of Claims, 1960)
William O. Schism and Robert Reinlie v. United States
316 F.3d 1259 (Federal Circuit, 2002)
Von Der Ruhr v. Immtech International, Inc.
570 F.3d 858 (Seventh Circuit, 2009)
US Salt, Inc. v. Broken Arrow, Inc.
563 F.3d 687 (Eighth Circuit, 2009)
Paul Decker v. GE Healthcare Inc.
770 F.3d 378 (Sixth Circuit, 2014)
Amgen Inc. v. Sanofi
987 F.3d 1080 (Federal Circuit, 2021)
Wi-Lan Inc. v. Sharp Electronics Corporation
992 F.3d 1366 (Federal Circuit, 2021)
Datamill, Inc. v. United States
91 Fed. Cl. 722 (Federal Claims, 2010)
American Savings Bank, F.A. v. United States
98 Fed. Cl. 291 (Federal Claims, 2011)
Baskett v. United States
2 Cl. Ct. 356 (Court of Claims, 1983)

Cite This Page — Counsel Stack

Bluebook (online)
Spectre Corporation v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/spectre-corporation-v-united-states-uscfc-2022.